Hyun-Jung Park

Title: Innovations by Inventor Hyun-Jung Park in Pharmaceutical Formulations

Introduction: Hyun-Jung Park is a notable inventor based in Gyeonggi-do, South Korea, who holds three patents in the pharmaceutical field. His inventions have significantly contributed to the improvement of drug formulations, particularly in enhancing the stability and effectiveness of existing medications.

Latest Patents: Among his latest innovations is a pharmaceutical composition that incorporates clomipramine, an antidepressant, alongside sildenafil, commonly known for treating erectile dysfunction. This formulation aims to enhance the stability of clomipramine by combining it with sildenafil or its pharmaceutically acceptable salts, specifically clomipramine hydrochloride and sildenafil citrate. The innovative aspect of this patent lies in the wet granulation method utilized for manufacturing the pharmaceutical formulation, which helps to preserve the stability of clomipramine.

Career Highlights: Throughout his career, Hyun-Jung Park has worked with reputable companies, including CTC Bio, Inc. and LG Electronics Inc. His work in these organizations has allowed him to hone his skills in pharmaceutical development and innovation.

Collaborations: In the course of his career, Hyun-Jung Park has collaborated with notable individuals in the field, including Hong Ryeol Jeon and Bong-Sang Lee. These collaborations have likely contributed to the breadth of knowledge and innovation present in his work.

Conclusion: Hyun-Jung Park exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents not only improve the stability of essential medications but also enhance patient care. As he continues to innovate, the potential for further advancements in pharmaceutical formulations remains promising.